Amedisys Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys (AMED) Tops Q1 EPS by 11c
April 29, 2015 7:10 AM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $301.6 million versus the consensus estimate of $300.17 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More